DrugPatentWatch Database Preview

Litigation Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

« Back to Dashboard

LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Docket		Date Filed	2016-05-06
Court	District Court, D. Delaware	Date Terminated	2018-08-16
Cause	35:271 Patent Infringement	Assigned To	Sue Lewis Robinson
Jury Demand	None	Referred To	Sherry R. Fallon
Parties	LEO LABORATORIES LIMITED
Patents	6,432,452; 6,787,161; 6,844,013; 7,410,656; 8,278,292; 8,372,827; 8,372,828; 8,377,919; 8,536,163; 8,716,271; 8,735,375; 9,820,959; 9,833,428; 9,833,429
Attorneys	Jeffrey H. Lerner
Firms	Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)

Date Filed	Document No.	Description	Snippet	Link To Document
2016-05-06	1		of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S.…the ’656 Patent, ’292 Patent, the ’827 Patent, the ’828 Patent, the ’919 Patent, the ’163 Patent, the ’…U.S. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. …the ’271 Patent”), and U.S. Patent No. 8,735,375 (“the ’375 Patent”) (collectively, “the Patents-in-Suit	External link to document
2016-07-21	15		of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S. …Declaratory Judgment of Invalidity of U.S. Patent No. 7,410,656) 17. Actavis realleges and incorporates…Declaratory Judgment of Noninfringement of U.S. Patent No. 7,410,656) 29. Actavis realleges and incorporates…. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. 8,716,271 (“	External link to document
2017-12-14	198		and Initial Infringement Charts for U.S. Patent Nos. 9,820,959; 9,833,428; 9,833,429 filed by LEO Laboratories…2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware	External link to document
2017-12-28	203		' 161 patent and the '013 patent claim priority to parent U.S. Patent No. 6,432,452 ("the…;828 patent, the '919 patent, the '163 patent, the '271 patent, the '375 patent, the … '013 patent), as well as the '656 patent, the '292 patent, the '827 patent, the '…The Aylward patents include the '656 patent, the '013 patent, and the' 161 patent. (D.I. 142… The Brown patents include the '292 patent, the '827 patent, the '828 patent, the '919	External link to document
2018-01-15	222		Terms in Need of Construction for U.S. Patent Nos. 9,820,959; 9,833,428; and 9,833,429 filed by Actavis…2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware	External link to document
2018-02-21	258		Supplemental Infringement Charts for U.S. Patent Nos. 8,278,292; 9,820,959; 9,833,428; and 9,833,429; (10…Plaintiffs' Supplemental Infringement Charts for U.S. Patent Nos. 9,416,084 and 9,676,698; (12) Plaintiffs' …2016 16 August 2018 1:16-cv-00333 830 Patent None District Court, D. Delaware	External link to document
2018-02-25	265		terms in U.S. Patent Nos. 7,410,656 (the “’656 Patent”) and 8,278,292 (the “’292 Patent”). D.I. 215,…Plaintiffs’ ownership of the Brown Patents or New Brown Patents. Patent ownership is essential to a …claims, including many in the Process Patents and New Brown Patents. Indeed, Defendants have not identified… claims from the six withdrawn Brown Patents, (U.S. Patent Nos. 8,372,827, 8,372,828, 8,377,919, 8,…when Plaintiffs asserted the New Brown Patents (U.S. Patent Nos. 9,820,959, 9,833,428, and 9,833,429	External link to document